Genome and count checks that prove a probiotic contains what its label says
TL;DR Strainmark is a testing service for probiotic makers and the pharma and supplement brands that buy their cultures. It sequences each strain, counts live cells across shelf life and screens for resistance genes, then hands over a batch report a brand can show its buyers. Brands pay per strain and per batch.
Probiotics in India sell on a strain name and a live-cell count printed on the pack, and hardly anyone checks either. In 2026 a team at a large Vellore teaching hospital sequenced 13 probiotics bought off Indian shelves. Five held fewer live cells than their labels claimed, one capsule by a factor of about 30.
Some contained a different species from the one printed, one sachet carried an unlisted contaminant, and isolates from four brands carried antibiotic resistance genes[1]. The study was small and lab-only, but it points at a quality gap that nobody is being paid to close.
So who checks? Right now, mostly nobody.
What it does, in regulatory terms: laboratory testing and documentation only. Strainmark makes no health claim and sells no product. Its reports support compliance with the FSSAI 2022 probiotic and nutraceutical regulations[2] or, for probiotics sold as drugs, with CDSCO requirements.
Here's how it works - a client sends cultures or finished packs. The lab sequences the whole genome of each strain, confirms the species and strain against the label, and flags resistance and virulence genes. Then it counts viable cells at release and at set points through shelf life, at the storage temperatures the product will really see. The output is a dated report per batch plus a strain file a brand can hand to retailers, hospital buyers or export customers.
I reframed the seed. It wanted engineered probiotics personalised to each user, but an engineered live organism swallowed as a product would need drug and genetic-engineering approvals with no Indian precedent I could find, and that is far beyond seed capital. Checking that the probiotics already on sale are what they claim is a real, near-term need.
There are three buyers. Contract culture makers want proof for their brand clients, pharma and supplement brands want cover before an audit or a bad headline, and exporters need documents for foreign buyers. I found no published Indian price list for this bundle. MTCC sells 16S sequencing and strain deposits but doesn't post fees on its home page[3]. My rough assumption is ₹40,000–1,00,000 per strain file, plus a smaller fee per batch.
The Vellore paper came out in May 2026[1] and names well-known brands, so procurement teams finally have a reason to ask awkward questions. FSSAI's 2022 regulations, operational from April 2022, made the probiotic category explicit and list permitted strains[4]. And whole-genome sequencing of a bacterial isolate is now routine work for Indian labs.
No public figure exists for what Indian brands spend on probiotic testing. The narrowest signal is the study itself - 5 of 13 products under their labelled count, and resistance genes in isolates from four brands[1]. Every brand named there, and every competitor of theirs, is a prospect. Treat demand as unproven until brands pay for a pilot.
MTCC at CSIR-IMTECH offers 16S identification and strain deposits[3], which covers one step. Large contract labs test food and drugs for tonnes of parameters. Academic groups, like the Vellore team, publish one-off audits[1].
I couldn't find an Indian service that packs strain identity, resistance screening and shelf-life counts into one file a brand can show. That bundle, and fast turnaround, is the gap.
| Difficulty | Moderate (38/100) |
| Starting capital | ₹60–110 L |
| Time to launch | 6–9 months |
The science is standard. The hard parts are getting NABL accreditation so reports carry weight with buyers, and writing reports that a brand manager can read without a microbiologist sitting next to them. Shelf-life studies also take months, so revenue from each client trickles in slowly.
No licence to test, but your clients' rules shape what your reports must show.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
Don't let AI sign off a strain identity or a safety finding. A wrong report here ends up on a retail shelf.
Want to work out the AI layer for Strainmark? Talk to Yash →
This suits a microbiologist with lab-management experience and some sales instinct. If you're hoping to build a consumer probiotic brand then this isn't it, honestly. Before you spend on sequencers, prove that five brands will pay for a pilot report on one product each, using an outsourced sequencing partner.
Expect roughly ₹60–110 L, mostly sequencing access, culture equipment and method validation. The free kit has the line-by-line capital breakdown.
No testing licence. NABL accreditation helps a lot, and your reports must match FSSAI or CDSCO rules depending on the product.
Yes, label accuracy is a global problem. Check which regulator covers probiotics in your market first.
The free Strainmark validation kit has the line-by-line capital breakdown, the effort scoring, the accreditation and food-law checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for brands and culture makers, and 5 assumptions to test. Download the kit →
Thinking about building Strainmark or something close to it? The make-or-break bit is getting brands to pay for a report that might show their product falls short, and that's the kind of thing I help founders work through. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.